Cargando…
Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report
Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant disorder associated with mutations in the KIT gene in the majority of cases. Although, exon 11 appears to be the hot spot region for approximately 95% of germline mutations, pathogenic variations have also been identified in...
Autores principales: | Engin, Gulgun, Eraslan, Serpil, Kayserili, Hülya, Kapran, Yersu, Akman, Haluk, Akyuz, Ali, Aykan, Nuri Faruk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Co., Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658632/ https://www.ncbi.nlm.nih.gov/pubmed/29098070 http://dx.doi.org/10.4329/wjr.v9.i9.365 |
Ejemplares similares
-
A gastrointestinal stromal tumor with mesenteric and retroperitoneal invasion
por: Engin, Gulgun, et al.
Publicado: (2007) -
Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon
por: Incorvaia, Lorena, et al.
Publicado: (2021) -
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016) -
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2019) -
Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations
por: Miyake, Kentaro, et al.
Publicado: (2018)